XPL is the native asset on the Plasma chain, and compliance has been a top priority since the project's inception. As Layer 1 stablecoin infrastructure, it combines Bitcoin-level security with EVM compatibility, with the main selling point being zero transaction fees for USDT transfers.

How to overcome the global regulatory hurdle? Plasma's approach is proactive compliance. Public sales are conducted through the Sonar system, and participants must complete KYC/KYB verification. Qualified US investors are also required to lock their tokens for an additional year to avoid being classified as securities by the SEC.

Geographically, the project has obtained an EU VASP license, has an office in Amsterdam, and fully aligns with MiCA and AMLD5 standards. On-chain risk control is also strict—integrating Chainalysis monitoring to track transaction flows in real-time, preventing money laundering and terrorist financing vulnerabilities.

Taxation varies greatly by region. Staking rewards for US users are considered taxable income and must be reported as capital gains; in the EU, utility tokens may be exempt from some VAT, but reporting obligations still exist. The project recommends all users consult local tax advisors as a responsible approach.

Token design also incorporates compliance considerations: with a total supply of 10 billion tokens, 10% is allocated for public sale, and the rest is distributed for validation and ecosystem incentives. It adopts an EIP-1559-style fee burn mechanism to enhance transaction transparency and facilitate regulatory tracking of data flows. For custody, institutional-grade custodians like Crypto.com provide SOC 2 certification services, offering double insurance.

Ultimately, XPL positions itself as an institution-friendly asset. With new regulations like the GENIUS Act being introduced, Plasma continues to iterate and optimize, aiming to find a balance between compliance and innovation in the stablecoin payment sector. By early 2026, the project’s $500 billion milestone reflects, to some extent, market recognition of this regulatory-aligned strategy.